Developer docs
API playgroundTry for free, no card

Search company profiles

Breast Cancer Trials

Full company profile

uuid000yf7z

Namestring
Breast Cancer Trials
Legal namestring
ANZ Breast Cancer Trials Group Limited
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Breast Cancer Trials (legal entity ANZ Breast Cancer Trials Group Limited) is an Australian registered charity founded in 1978 and headquartered in Newcastle, NSW. It is the largest independent oncology clinical trials research group in Australia and New Zealand, running a coordinated multi-centre clinical trials program for breast cancer treatment, prevention, and cure. The organization coordinates approximately 95 clinical trials across recruitment, follow-up, analysis, and publication, engaging 1,068 researchers across 119 institutions in Australia and New Zealand plus 68 international sites, and collaborates with 21 international clinical trial groups including BIG, IBCSG, GBG, SOLTI, and TRIO. Core infrastructure includes the BCT Biobank in Newcastle holding thousands of specimens linked to clinical outcome data, a Remote Telehealth Pre-Screening Process to broaden rural and remote patient access, and a Clinical Fellowship Program supporting four new research clinicians annually.

The organization is funded through a diversified donor and fundraising model rather than commercial pricing. Revenue streams include individual one-time and monthly donations (with donations of $2+ AUD tax-deductible under DGR status), gifts in wills, workplace giving, corporate partnerships, merchandise such as the Australian Women's Health Diary, and a portfolio of national community fundraising events including the Pink Bloom Party, Big Bold Walk, Big Bold Swim, Get Active, and the long-running Tee Off golf initiative. It serves approximately 38,000 supporters and has supported 17,910+ clinical trial participants since inception, contributing to 1,361+ peer-reviewed scientific publications and practice-changing studies such as TAILORx, SOFT & TEXT, OlympiA, HERA, and BIG 1-98. Governance is provided by a Board of Directors under a not-for-profit structure, with no parent company and ACNC charity registration.

Short descriptiontext

Breast Cancer Trials is an Australian charitable clinical trials research organization founded in 1978 that coordinates breast cancer treatment and prevention trials across 119 institutions in Australia and New Zealand, supported by a 1,068-researcher network, a biobank, and community donations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNewcastle, Australia
HQ citystring
Newcastle
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trials research, breast cancer research, oncology clinical trials, cancer treatment research, clinical research services
Industry3 codes
1Clinical Trial Site Operations & Study Coordination
CodeHLAGACAEPrimaryYes
2Gynecologic Oncology & Women’s Cancer Centers
CodeHLAFAJAKPrimaryNo
3Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
CodeHLAAANAIPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Oncology Clinical Trials Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Individual Donations
TypeSubscription Recurring
Description

One-time and monthly donations from individuals, with tax-deductible status for donations of $2 or more in Australia.

breastcancertrials.org.au
2Fundraising Events
TypeOne Time License
Description

Revenue generated from events including Pink Bloom Party, Big Bold Walk, Big Bold Swim, Get Active sporting events, Tee Off golf events, and community fundraising activities.

breastcancertrials.org.au
3Gifts in Wills
TypeLicensing Royalties
Description

Legacy giving program where supporters leave a gift in their Will to ensure ongoing support beyond their lifetime.

breastcancertrials.org.au
4Merchandise Sales
TypeHardware Sales
Description

Sale of merchandise including the Australian Women's Health Diary and branded items to raise funds for research.

breastcancertrials.org.au
5Corporate Partnerships
TypeAffiliate Referral
Description

Corporate donations and sponsorship arrangements with businesses supporting the breast cancer trials research program.

breastcancertrials.org.au
6Workplace Giving
TypeSubscription Recurring
Description

Employee giving program allowing workers to make regular pre-tax donations through their employer's payroll system.

breastcancertrials.org.au
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details2 tiers
1One-time donation amounts: $30, $32, $55, $75, $85, $100, $250
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Suggested one-time donation amounts ranging from $30 to $250 AUD

breastcancertrials.org.au
2Monthly giving program with flexible contribution amounts
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly donors provide ongoing support to ensure latest breast cancer treatments reach those in need

breastcancertrials.org.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Breast Cancer Trials designs, coordinates, and conducts a multi-centre national and international clinical trials research program for breast cancer treatment, prevention, and cure, encompassing approximately 95 clinical trials across recruitment, follow-up, analysis, and publication stages. The program is delivered through 119 institutions in Australia and New Zealand and 68 international sites, supported by translational research via the BCT Biobank, a Remote Telehealth Pre-Screening service for rural and regional patients, a Clinical Fellowship Program for emerging researchers, and patient-facing decision-support tools (iPrevent and the Neoadjuvant Patient Decision Aid).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 17,910+ trial participants have contributed to clinical trials research since 1978
+3 more records
Product overview1 text field

Breast Cancer Trials operates as a clinical trials research organization conducting a coordinated multi-centre national and international clinical trials program for breast cancer treatment, prevention, and cure. The core offering is the Clinical Trials Research Program encompassing approximately 95 clinical trials, supported by services including the Remote Telehealth Pre-Screening Process for broader patient access, a Translational Research/Biobank for specimen analysis, and a Clinical Fellowship Program for researcher development. The organization also runs a fundraising platform including events (Pink Bloom Party, Big Bold Walk, Big Bold Swim, Tee Off), merchandise (Australian Women's Health Diary), and provides researcher tools including a member portal and publications database. Patient-facing digital tools include iPrevent for risk assessment and a Neoadjuvant Patient Decision Aid. The organization collaborates with 119 institutions in Australia and New Zealand and 21 international clinical trial groups.

Product and service6 records
1Clinical Trials Research Program
Description

Coordinated multi-centre national and international breast cancer clinical trials research program encompassing approximately 95 trials across recruitment, follow-up, analysis and publication, delivered through 119 ANZ institutions and 68 international sites. Includes currently recruiting trials such as OLIO, PROSPECTIVE, and ROSALIE.

2Remote Telehealth Pre-Screening Process
Description

Remote telehealth service that enables rural, regional and remote patients to complete pre-screening for molecularly targeted breast cancer clinical trials in their local community, including blood test kits and pathology laboratory liaison for tissue samples.

3Translational Research / BCT Biobank
Description

Biobank resource located in Newcastle that holds thousands of specimens from Breast Cancer Trials clinical trials, linked to detailed clinical outcome data, supporting local researchers in analyses that influence the development of new BCT clinical research. Funded by BCRF grants since 2010.

4Clinical Fellowship Program
Description

Program supporting the next generation of breast cancer researchers through financial assistance for junior research clinicians, with four Clinical Fellows supported annually.

5Fundraising Events Platform
Description

National fundraising program encompassing Pink Bloom Party (October), Big Bold Walk (June), Big Bold Swim (February), Get Active sporting events, Tee Off golf initiative (running since 1996 and raising over $4 million), Race For A Cure, and community fundraising activities.

6Australian Women's Health Diary
Description

Annual health diary product sold by Breast Cancer Trials to raise funds for breast cancer clinical trials research, targeting women who want to make a difference to their own lives and others.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1Clinical Oncological Society of Australia (COSA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BCT is a sustaining member of COSA, the peak national body for health professionals working in cancer control in Australia.

breastcancertrials.org.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International collaboration ensuring women and specialists in Australia and New Zealand get early access to new, promising treatments and placing BCT at the forefront of research progress.

3International Breast Cancer Study Group (IBCSG)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with IBCSG (Switzerland and USA) on international clinical trials for breast cancer treatment and prevention.

breastcancertrials.org.au
4German Breast Group (GBG)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on international clinical trials with the German Breast Group.

breastcancertrials.org.au
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International clinical trial collaboration with Alliance Foundation Trials based in the USA.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International collaboration with ABCSG on breast cancer clinical trials.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International collaboration with Canadian Cancer Trials Group.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International collaboration with Cancer Trials Ireland.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International clinical trial collaboration with SOLTI based in Spain.

10Taiwan Breast Cancer Consortium (TBCC)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International collaboration with Taiwan Breast Cancer Consortium.

breastcancertrials.org.au
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International collaboration with TRIO (France and Canada) on translational research in oncology.

12Australian New Zealand Clinical Trials Registry
Strategic tierMajorTypeStrategic or Co-development Partner
Description

BCT clinical trials are registered on the ANZCTR, enabling patients and researchers to access information about breast cancer clinical trials available across Australia and New Zealand.

breastcancertrials.org.au
13119 Australian and New Zealand Institutions
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Network of hospitals and cancer treatment centres across all Australian states/territories and New Zealand participating in BCT clinical trials research program, coordinated through BCT's head office in Newcastle.

breastcancertrials.org.au
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest US-based breast cancer charity funding research, community health and advocacy globally. Comparable as a major breast cancer non-profit with similar fundraising and research funding model, but at much larger scale.

TypeBroad incumbent
Description

World's largest cancer research charity funding research across all cancer types. Comparable as a major cancer research non-profit with similar mission and fundraising model, though covering all cancers rather than breast alone.

TypeBroad incumbent
Description

Largest Australian cancer charity umbrella organization funding research, advocacy and patient support across all cancer types. Comparable as a major Australian cancer non-profit competing for similar donor funding, but with broader scope.

4International Breast Cancer Study Group (IBCSG)
TypeDirect peer
Description

International cooperative group based in Switzerland conducting breast cancer clinical trials. Direct peer as a clinical trials research organization with similar operational model and ongoing partnership with BCT.

TypeDirect peer
Description

US-based clinical trials cooperative group and BCT collaboration partner. Comparable as an oncology-focused multi-center trial coordinating organization with academic medical center network.

TypeDirect peer
Description

International non-profit network coordinating breast cancer clinical trials globally. BCT is a member of BIG and they collaborate closely; BIG is the umbrella organization with similar trial-coordination mission across multiple countries.

TypeDirect peer
Description

Major US-based clinical trials cooperative group conducting cancer treatment trials. Comparable structure as a large multi-institutional oncology trials network with similar coordination and protocol development functions.

TypeDirect peer
Description

Australia's other major breast cancer-focused non-profit, funding research and clinical trials. Directly comparable as a domestic breast cancer charity with overlapping donor base, though NBCF is more research-grant oriented rather than trial-coordinating.

TypeDirect peer
Description

US-based cooperative group conducting oncology clinical trials across multiple cancer types including breast. Comparable as a multi-center clinical trials research organization with academic institution network and NCI funding.

10McGrath Foundation
TypeRegional player
Description

Australian breast cancer non-profit funding breast care nurses rather than direct clinical trials. Comparable as an Australian breast cancer charity sharing donor base, but focused on patient care services rather than research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Breast Cancer Trials

Oncology Clinical Trials Researchbreastcancertrials.org.au

Breast Cancer Trials is an Australian charitable clinical trials research organization founded in 1978 that coordinates breast cancer treatment and prevention trials across 119 institutions in Australia and New Zealand, supported by a 1,068-researcher network, a biobank, and community donations.

What Breast Cancer Trials does

Breast Cancer Trials (legal entity ANZ Breast Cancer Trials Group Limited) is an Australian registered charity founded in 1978 and headquartered in Newcastle, NSW. It is the largest independent oncology clinical trials research group in Australia and New Zealand, running a coordinated multi-centre clinical trials program for breast cancer treatment, prevention, and cure. The organization coordinates approximately 95 clinical trials across recruitment, follow-up, analysis, and publication, engaging 1,068 researchers across 119 institutions in Australia and New Zealand plus 68 international sites, and collaborates with 21 international clinical trial groups including BIG, IBCSG, GBG, SOLTI, and TRIO. Core infrastructure includes the BCT Biobank in Newcastle holding thousands of specimens linked to clinical outcome data, a Remote Telehealth Pre-Screening Process to broaden rural and remote patient access, and a Clinical Fellowship Program supporting four new research clinicians annually.

The organization is funded through a diversified donor and fundraising model rather than commercial pricing. Revenue streams include individual one-time and monthly donations (with donations of $2+ AUD tax-deductible under DGR status), gifts in wills, workplace giving, corporate partnerships, merchandise such as the Australian Women's Health Diary, and a portfolio of national community fundraising events including the Pink Bloom Party, Big Bold Walk, Big Bold Swim, Get Active, and the long-running Tee Off golf initiative. It serves approximately 38,000 supporters and has supported 17,910+ clinical trial participants since inception, contributing to 1,361+ peer-reviewed scientific publications and practice-changing studies such as TAILORx, SOFT & TEXT, OlympiA, HERA, and BIG 1-98. Governance is provided by a Board of Directors under a not-for-profit structure, with no parent company and ACNC charity registration.

Breast Cancer Trials firmographics

Firmographics
Name
Breast Cancer Trials
Legal name
ANZ Breast Cancer Trials Group Limited
Website
https://breastcancertrials.org.au
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
11–50 employees
Short description
Breast Cancer Trials is an Australian charitable clinical trials research organization founded in 1978 that coordinates breast cancer treatment and prevention trials across 119 institutions in Australia and New Zealand, supported by a 1,068-researcher network, a biobank, and community donations.
Ownership category
akta.pro rank

Breast Cancer Trials industry classification

Industry
Product category
Oncology Clinical Trials Research
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Clinical Trial Site Operations & Study Coordination (HLAGACAE)
akta.pro secondary industries
Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

Keywords

  • Clinical trials research
  • Breast cancer research
  • Oncology clinical trials
  • Cancer treatment research
  • Clinical research services

Where Breast Cancer Trials is headquartered

Location

Headquarters

HQ city
Newcastle
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Breast Cancer Trials business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Individual Donations: One-time and monthly donations from individuals, with tax-deductible status for donations of $2 or more in Australia.
  2. Fundraising Events: Revenue generated from events including Pink Bloom Party, Big Bold Walk, Big Bold Swim, Get Active sporting events, Tee Off golf events, and community fundraising activities.
  3. Gifts in Wills: Legacy giving program where supporters leave a gift in their Will to ensure ongoing support beyond their lifetime.
  4. Merchandise Sales: Sale of merchandise including the Australian Women's Health Diary and branded items to raise funds for research.
  5. Corporate Partnerships: Corporate donations and sponsorship arrangements with businesses supporting the breast cancer trials research program.
  6. Workplace Giving: Employee giving program allowing workers to make regular pre-tax donations through their employer's payroll system.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goOne-time donation amounts: $30, $32, $55, $75, $85, $100, $250
SubscriptionMonthlyMonthly giving program with flexible contribution amounts

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Breast Cancer Trials product offering

Product offering

Core offering

Breast Cancer Trials designs, coordinates, and conducts a multi-centre national and international clinical trials research program for breast cancer treatment, prevention, and cure, encompassing approximately 95 clinical trials across recruitment, follow-up, analysis, and publication stages. The program is delivered through 119 institutions in Australia and New Zealand and 68 international sites, supported by translational research via the BCT Biobank, a Remote Telehealth Pre-Screening service for rural and regional patients, a Clinical Fellowship Program for emerging researchers, and patient-facing decision-support tools (iPrevent and the Neoadjuvant Patient Decision Aid).

Product overview

Breast Cancer Trials operates as a clinical trials research organization conducting a coordinated multi-centre national and international clinical trials program for breast cancer treatment, prevention, and cure. The core offering is the Clinical Trials Research Program encompassing approximately 95 clinical trials, supported by services including the Remote Telehealth Pre-Screening Process for broader patient access, a Translational Research/Biobank for specimen analysis, and a Clinical Fellowship Program for researcher development. The organization also runs a fundraising platform including events (Pink Bloom Party, Big Bold Walk, Big Bold Swim, Tee Off), merchandise (Australian Women's Health Diary), and provides researcher tools including a member portal and publications database. Patient-facing digital tools include iPrevent for risk assessment and a Neoadjuvant Patient Decision Aid. The organization collaborates with 119 institutions in Australia and New Zealand and 21 international clinical trial groups.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trials Research Program Coordinated multi-centre national and international breast cancer clinical trials research program encompassing approximately 95 trials across recruitment, follow-up, analysis and publication, delivered through 119 ANZ institutions and 68 international sites. Includes currently recruiting trials such as OLIO, PROSPECTIVE, and ROSALIE.
  • Remote Telehealth Pre-Screening Process Remote telehealth service that enables rural, regional and remote patients to complete pre-screening for molecularly targeted breast cancer clinical trials in their local community, including blood test kits and pathology laboratory liaison for tissue samples.
  • Translational Research / BCT Biobank Biobank resource located in Newcastle that holds thousands of specimens from Breast Cancer Trials clinical trials, linked to detailed clinical outcome data, supporting local researchers in analyses that influence the development of new BCT clinical research. Funded by BCRF grants since 2010.
  • Clinical Fellowship Program Program supporting the next generation of breast cancer researchers through financial assistance for junior research clinicians, with four Clinical Fellows supported annually.
  • Fundraising Events Platform National fundraising program encompassing Pink Bloom Party (October), Big Bold Walk (June), Big Bold Swim (February), Get Active sporting events, Tee Off golf initiative (running since 1996 and raising over $4 million), Race For A Cure, and community fundraising activities.
  • Australian Women's Health Diary Annual health diary product sold by Breast Cancer Trials to raise funds for breast cancer clinical trials research, targeting women who want to make a difference to their own lives and others.

Quantifiable outcome

  • 17,910+ trial participants have contributed to clinical trials research since 1978
  • +3 more outcomes

Companies that use Breast Cancer Trials

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Breast Cancer Trials technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Breast Cancer Trials partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and major.

  • Clinical Oncological Society of Australia (COSA)coreStrategic or Co-development PartnerBCT is a sustaining member of COSA, the peak national body for health professionals working in cancer control in Australia.
  • Breast International Group (BIG)coreStrategic or Co-development PartnerInternational collaboration ensuring women and specialists in Australia and New Zealand get early access to new, promising treatments and placing BCT at the forefront of research progress.
  • International Breast Cancer Study Group (IBCSG)coreStrategic or Co-development PartnerCollaboration with IBCSG (Switzerland and USA) on international clinical trials for breast cancer treatment and prevention.
  • German Breast Group (GBG)coreStrategic or Co-development PartnerCollaboration on international clinical trials with the German Breast Group.
  • Alliance Foundation Trials (USA)majorStrategic or Co-development PartnerInternational clinical trial collaboration with Alliance Foundation Trials based in the USA.
  • Austrian Breast & Colorectal Cancer Study Group (ABCSG)majorStrategic or Co-development PartnerInternational collaboration with ABCSG on breast cancer clinical trials.
  • Canadian Cancer Trials Group (CCTG)majorStrategic or Co-development PartnerInternational collaboration with Canadian Cancer Trials Group.
  • Cancer Trials Ireland (CTI)majorStrategic or Co-development PartnerInternational collaboration with Cancer Trials Ireland.
  • SOLTI (Spain)majorStrategic or Co-development PartnerInternational clinical trial collaboration with SOLTI based in Spain.
  • Taiwan Breast Cancer Consortium (TBCC)majorStrategic or Co-development PartnerInternational collaboration with Taiwan Breast Cancer Consortium.
  • Translational Research in Oncology (TRIO)majorStrategic or Co-development PartnerInternational collaboration with TRIO (France and Canada) on translational research in oncology.
  • Australian New Zealand Clinical Trials RegistrymajorStrategic or Co-development PartnerBCT clinical trials are registered on the ANZCTR, enabling patients and researchers to access information about breast cancer clinical trials available across Australia and New Zealand.
  • 119 Australian and New Zealand InstitutionscoreStrategic or Co-development PartnerNetwork of hospitals and cancer treatment centres across all Australian states/territories and New Zealand participating in BCT clinical trials research program, coordinated through BCT's head office in Newcastle.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Breast Cancer Trials competitors and assessment

Company assessment

Broad incumbents

  • Susan G. Komen: Largest US-based breast cancer charity funding research, community health and advocacy globally. Comparable as a major breast cancer non-profit with similar fundraising and research funding model, but at much larger scale.
  • Cancer Research UK: World's largest cancer research charity funding research across all cancer types. Comparable as a major cancer research non-profit with similar mission and fundraising model, though covering all cancers rather than breast alone.
  • Cancer Council Australia: Largest Australian cancer charity umbrella organization funding research, advocacy and patient support across all cancer types. Comparable as a major Australian cancer non-profit competing for similar donor funding, but with broader scope.

Direct peers

  • International Breast Cancer Study Group (IBCSG): International cooperative group based in Switzerland conducting breast cancer clinical trials. Direct peer as a clinical trials research organization with similar operational model and ongoing partnership with BCT.
  • Alliance for Clinical Trials in Oncology: US-based clinical trials cooperative group and BCT collaboration partner. Comparable as an oncology-focused multi-center trial coordinating organization with academic medical center network.
  • Breast International Group (BIG): International non-profit network coordinating breast cancer clinical trials globally. BCT is a member of BIG and they collaborate closely; BIG is the umbrella organization with similar trial-coordination mission across multiple countries.
  • ECOG-ACRIN Cancer Research Group: Major US-based clinical trials cooperative group conducting cancer treatment trials. Comparable structure as a large multi-institutional oncology trials network with similar coordination and protocol development functions.
  • National Breast Cancer Foundation (Australia): Australia's other major breast cancer-focused non-profit, funding research and clinical trials. Directly comparable as a domestic breast cancer charity with overlapping donor base, though NBCF is more research-grant oriented rather than trial-coordinating.
  • NRG Oncology: US-based cooperative group conducting oncology clinical trials across multiple cancer types including breast. Comparable as a multi-center clinical trials research organization with academic institution network and NCI funding.

Regional players

  • McGrath Foundation: Australian breast cancer non-profit funding breast care nurses rather than direct clinical trials. Comparable as an Australian breast cancer charity sharing donor base, but focused on patient care services rather than research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Breast Cancer Trials social profiles

Digital presence

Breast Cancer Trials compliance and trust

Trust signal

Compliance4 records

Breast Cancer Trials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Breast Cancer Trials leadership team

Management profile

Number of profiles

Profiles2 records

Breast Cancer Trials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Breast Cancer Trials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Breast Cancer Trials

What does Breast Cancer Trials do?

Breast Cancer Trials designs, coordinates, and conducts a multi-centre national and international clinical trials research program for breast cancer treatment, prevention, and cure, encompassing approximately 95 clinical trials across recruitment, follow-up, analysis, and publication stages. The program is delivered through 119 institutions in Australia and New Zealand and 68 international sites, supported by translational research via the BCT Biobank, a Remote Telehealth Pre-Screening service for rural and regional patients, a Clinical Fellowship Program for emerging researchers, and patient-facing decision-support tools (iPrevent and the Neoadjuvant Patient Decision Aid).

Is Breast Cancer Trials a public or private company?

Breast Cancer Trials is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Breast Cancer Trials founded?

Breast Cancer Trials was founded in 1978. It employs 11 to 50 people.

Where is Breast Cancer Trials based?

Breast Cancer Trials is headquartered in Newcastle, Australia, in the Oceania region.

How does Breast Cancer Trials make money?

Six revenue lines are on record. Individual Donations are the primary driver. The others are fundraising Events, gifts in Wills, merchandise Sales, corporate Partnerships and workplace Giving.

Who are Breast Cancer Trials's main competitors?

Broad incumbents on record are Susan G. Komen, Cancer Research UK and Cancer Council Australia. Direct peers are International Breast Cancer Study Group (IBCSG), Alliance for Clinical Trials in Oncology, Breast International Group (BIG), ECOG-ACRIN Cancer Research Group, National Breast Cancer Foundation (Australia) and NRG Oncology. McGrath Foundation is listed as a regional player.

Does Breast Cancer Trials have an API?

No public API is recorded for Breast Cancer Trials.

What industry is Breast Cancer Trials in?

Breast Cancer Trials's product category is Oncology Clinical Trials Research. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAFAJAK, Gynecologic Oncology & Women’s Cancer Centers. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals